Immunohistological and western blot analysis of the tumour tissue revealed a significant upregulation of CD44, phosphorylated Hck, as well as activated Src (via ablation of the inactivating residue at Y527) in the day 9 tumours from animals treated with DTX as compared with vehicle-treated controls. The gene discussed is HCK; the disease is neoplasm.